SDGR logo

SCHRODINGER INC

SDGRNASDAQ
πŸ† #1919 by market capUS Equity
$932.63β–² $6.34 (+0.68%)
Simulated price
πŸ””
Track SDGR
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.7%
7dβ–² 3089.6%
14dβ–² 3802.2%
30dβ–² 4680.3%
ytdβ–² 5119.0%
1yβ–² 4548.0%
🏦Market Cap
$2.20B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+23.3%
Healthy
πŸ“ŠGross Margin
56.9%
Healthy
πŸ’΅FCF Margin
-12.5%
Thin
βš–οΈP/S Ratio
8.5x
Elevated
Otter Score
64
Fair

Trading Snapshot

Day Range
$928.02 – $944.50
52-Week Range
$10.95 – $31.60
Volume
$2.31B
Avg Volume
$1.80B
Shares Outstanding
74.7M
Next Earnings
Dec 3, 2026

Fundamentals Snapshot

Annual Revenue
$256M
Last Q Revenue
$59M
P/E Ratio
-39.9
P/S Ratio
8.5x
EPS (TTM)
$-0.73
Dividend Yield
0.00%
Dilution (1yr)
+1.1%

Why Investors Own SDGR

  • βœ“High-growth profile β€” revenue up -9.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 31% gross margin and 24% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SDGR logo

SCHRODINGER INC

SDGR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$256Mβ–² +23.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
55.7%β–Ό βˆ’12.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$167Mβ–Ό βˆ’20.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$12Mβ–Ό βˆ’107.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
73.4Mβ–² +1.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$121Mβ–² +$92M YoY
StockOtter Β· stockotter.space

About SCHRODINGER INC

SchrΓΆdinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. SchrΓΆdinger, Inc. was incorporated in 1990 and is based in New York, New York.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$1,025.46
β–² +10.0% Upside
High Target$1,169.21
Low Target$947.97
Based on 12 analysts

Latest News & Updates